VDR and Hypercalcemia: Furthermore, the disproportionality analysis showed that the possible consequences of hypercalcemia such as nephrolithiasis, cardiac disorders, neurological disorders, and pancreatitis were associated with active (i.e., 1α-hydroxylated derivatives) VDR agonists only.